Carrot Fertility has partnered with Priority Health to offer two design solutions for fully-funded and self-funded employer groups. These solutions include support for fertility treatment, pregnancy, postpartum care, gestational surrogacy, adoption, menopause and low testosterone.
Offering safe affordable family-forming programs for everyone, including vulnerable or under-served employee populations, represents an opportunity for employers to build a caring culture that also will benefit the bottom line.
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Ovia Health unveiled a new fertility and family-building benefit for employers and health plans that includes financial support, care navigation services and one-on-one concierge support.
Amazon selected Maven Clinic to provide fertility and family building support to its global employees across 50 countries. This includes support from care advocates and unlimited access to its virtual specialists like OB/GYNs and reproductive endocrinologists.
A new startup named Zuri Fertility recently launched. Its platform provides resources for patients who are trying to conceive — including telehealth, at-home testing, prescriptions, mental health services, education and care coordination.
Through Morgan Health's $25 million investment, Kindbody will continue expanding into new markets. It will also grow its services, including menopause treatment and male fertility.
Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources.
Through Maven's acquisition, Naytal’s over 50 providers will join Maven’s platform, more than doubling the company’s number of providers in the U.K. Maven will also be able to sign on additional U.K.-based clients.
Medical device company Contraline became the first to implant a hydrogel-based male contraceptive gel into humans in a clinical trial. Implanted during a noninvasive 10-minute office procedure, the gel promises to block the flow of sperm to the vas deferens. If proven safe and effective, it could become the first nonhormonal, reversible contraceptive for men on the market.
Bay Area startup Counsyl aims to bring carrier screening to the mainstream, so that parents can know if their child is likely to have a serious genetic disease.